InkSpace Imaging Small Body Array (SBA12PH15x)
Inkspace Imaging, Inc. · Decision date Oct 5, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K262813 on 2026-10-05, clearing the InkSpace Imaging Small Body Array (SBA12PH15x) under regulation 892.1000, product code MOS, classification name "Coil, Magnetic Resonance, Specialty." The applicant is Inkspace Imaging, Inc. of Pleasanton, California; the submission was received 08/07/2026 and handled as a Special review by the Radiology panel. SESE denotes 510(k) clearance, not premarket approval of a new device system.
The record identifies the cleared item as a specialty magnetic resonance coil intended for small-body imaging, but the public summary does not state the predicate device, the specific components or design changes assessed, or any performance data supporting equivalence. Field strength compatibility, clinical indications, and labeling terms are likewise absent from the available text and should be confirmed in the clearance letter and device labeling rather than inferred here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262813
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Inkspace Imaging, Inc.
- Product code
- MOS
- Decision code
- SESE
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Coil, Magnetic Resonance, Specialty.
- Applicant
- Inkspace Imaging, Inc.
- Product code
- MOS
- FDA device class
- 2
FDA decision timeline
K262813 received
Application receipt date recorded by FDA.
K262813 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Inkspace Imaging, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Pleasanton, CA
Sources and methodology
- Original FDA record: K262813
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records